RFI-720617-22-002: USAID/Uganda Health Activity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Uganda USAID-Kampala notices from 2021.
Uganda USAID-Kampala offered grants to any type of organization. Applications closed on January 24, 2022.
From the official notice on Grants.gov, last changed December 13, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingRequired
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| 72061722RFA00003 | July 18, 2022 | Closed August 25, 2022 | Closed |
| DRAFT-NOFO-720617-22-001 | April 4, 2022 | Closed April 15, 2022 | Closed |
Key dates
| Posted | December 13, 2021 |
|---|---|
| Deadline | January 24, 2022 |
| Archived by Grants.gov | January 31, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
The United States Government, represented by the U.S. Agency for International Development (USAID) Mission in Uganda, seeks to inform interested organizations about an upcoming planned integrated health funding activity, tentatively titled the Uganda Health Activity. This RFI also requests written feedback on the proposed Uganda Health Activity draft program description and key personnel requirements (included as Attachment II). The proposed Uganda Health Activity aims to increase access to and use of quality healthcare services and improve the performance of the health system at subnational levels in priority districts. Intended high-level results include: 1) improved access to and use of quality maternal, newborn, and child health (MNCH); family planning (FP)/reproductive health (RH); nutrition; and water, sanitation, and hygiene (WASH)/infection prevention and control (IPC) health services at facility- and community-levels; 2) enhanced local ownership and leadership for sustainable health outcomes; and 3) strengthened health system resilience at the regional-, district-, and community-levels. The Uganda Health Activity will also strengthen the capacity of local PEPFAR implementing partners (IPs) to lead and sustain the epidemic response as part of sustainability efforts. This RFI is issued solely for planning purposes and to improve the potential activity design. The RFI does NOT commit USAID to issue a Notice of Funding Opportunity or make an award on the basis of this RFI. All response costs incurred in providing feedback to this RFI are at the respondent’s expense. Please note that responding to this RFI will not give any advantage to or preclude any organization or individual from responding to any Notice of Funding Opportunity (NOFO) that may be subsequently issued. If USAID releases a NOFO, it will be posted on www.grants.gov and/or www.sam.gov. It is the potential applicant’s responsibility to monitor these websites for the release of further information and updates. Responses to this RFI must be submitted by email to kampalausaidsolicita@usaid.gov no later than the date and time shown above. Do not submit any applications at this time. Information received in response to this RFI shall become the property of USAID. Therefore, information that cannot be shared should not be sent. Please note that respondents will not receive individualized feedback on their submission.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-720617-22-002 still open?
No. It closed on January 24, 2022.
Who can apply for USAID/Uganda Health Activity?
Uganda USAID-Kampala accepted applications from any type of organization.
What is the deadline for USAID/Uganda Health Activity?
Closed January 24, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)